Metraipolis › archive › dc_8db2abd516f5
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancer — Europe PMC PMID:41992834
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41992834
- DOI
- 10.1093/oncolo/oyag142
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T08:47:16.263Z
- SHA-256 of the archived text
03530d678945baf4588831a8bd907aec156056d9f579f86e22978b1bd983e80c- Stable URL of this page
https://metraipolis.com/documento/dc_8db2abd516f5
How to cite
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancer — Europe PMC PMID:41992834 — Europe PMC (en), https://europepmc.org/article/MED/41992834 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8db2abd516f5 (Metraipolis archive dc_8db2abd516f5, sha256 03530d678945baf4588831a8bd907aec156056d9f579f86e22978b1bd983e80c)
BibTeX
@misc{dc8db2abd516f5,
title = {Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancer — Europe PMC PMID:41992834},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41992834},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8db2abd516f5; sha256 03530d678945baf4588831a8bd907aec156056d9f579f86e22978b1bd983e80c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41992834. Agents can read the archived copy with the MCP tool read_document.